Are you living with major depressive disorder (MDD)? Are you experiencing persistent sadness, hopelessness, irritability, restlessness, guilt or worthlessness? Indago is collaborating with Axsome Therapeutics on a research study to assess the safety of solriamfetol in adults with depression (SOL-MDD-301 or PARADIGM).
C. diff is a leading cause of infectious diarrhea in adults 65 and older that can result in severe illness and recurrent symptoms. Learn about Pfizer’s new vaccine study which may help to protect against C. diff infection.
This clinical trial’s purpose is to test a new study drug, called AZD0780. The study drug is a small molecule PCSK9 inhibitor that aims to lower the levels of “bad cholesterol” in the blood.
Volunteers who join the trial will take AZD0780(study drug) orally, every day for 12 weeks, which is about three months. Your participation in the study will help to determine the
effectiveness, safety, and tolerability of AZD0780(study drug) and how it affects LDL-C (bad cholesterol) levels and levels of other types of fat in your blood.
Contact us for more information: 786-772-0510
Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.
Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria.
We are looking for subjects who are affected by uncontrolled hypertension to participate in a research study to investigate a new experimental treatment.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.
The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).
Learn more about a clinical trial of a study drug for people who are living with HFrEF. Also called systolic heart failure, HFrEF is a type of cardiac dysfunction where the heart is too weak to pump enough blood around the body.
Learn more about Pfizer’s research study for an investigational COVID-19 and flu combination vaccine.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)